Adherium Limited (ADR.AX)

AUD 0.01

(9.09%)

Market Cap (In AUD)

9.93 Million

Revenue (In AUD)

840.98 Thousand

Net Income (In AUD)

-10.22 Million

Avg. Volume

1.21 Million

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.009-0.093
PE
-
EPS
-
Beta Value
2.404
ISIN
AU000000ADR1
CUSIP
Q0137R108
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Paul Mastoridis
Employee Count
-
Website
https://www.adherium.com
Ipo Date
2015-08-26
Details
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around a patient's inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal. The company was incorporated in 2001 and is based in Auckland, New Zealand.